EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:50855 - antiatherogenic agent
| ChEBI ID | CHEBI:50855 |
| ChEBI Name | antiatherogenic agent |
| Stars | |
| Definition | A cardiovascular drug that prevents atherogenesis, the accumulation of lipid-containing plaques on the innermost layers of the arteries. Compare with antiatherosclerotic agent. |
| Last Modified | 5 March 2025 |
| Submitter | Inma Spiteri |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| antiatherogenic agent (CHEBI:50855) is a cardiovascular drug (CHEBI:35554) |
| Incoming Relation(s) |
| (R,R,R)-α-tocopherol (CHEBI:18145) has role antiatherogenic agent (CHEBI:50855) |
| (9E,11E)-octadecadienoic acid (CHEBI:88464) has role antiatherogenic agent (CHEBI:50855) |
| beauveriolide I (CHEBI:180490) has role antiatherogenic agent (CHEBI:50855) |
| ghrelin (CHEBI:75431) has role antiatherogenic agent (CHEBI:50855) |
| ochnaflavone (CHEBI:194126) has role antiatherogenic agent (CHEBI:50855) |
| PD-146176 (CHEBI:173098) has role antiatherogenic agent (CHEBI:50855) |
| punicalagin (CHEBI:167695) has role antiatherogenic agent (CHEBI:50855) |
| Synonyms | Source |
|---|---|
| antiatherogenic drug | ChEBI |
| anti-atherogenic drug | ChEBI |
| antiatherogenic agents | ChEBI |
| anti-atherogenic agents | ChEBI |
| anti-atherogenic agent | ChEBI |
| antiatherogenic agent | ChEBI |
| Citations |
|---|